Le Lézard
Classified in: Ebola virus, Health
Subject: SVY

Merck Manuals Answers: What is Gout?



KENILWORTH, N.J., Sept. 27, 2017 /PRNewswire/ -- It's a pain known to be so excruciating that the weight of a bed sheet can't even be tolerated. Gout affects millions of Americans every year, yet it's still a widely misunderstood condition.

To provide clarity on the risk factors, symptoms and treatment of this disorder, Dr. Brian Mandell, MD and Professor and Chairman of Academic Medicine at the Cleveland Clinic answers five common questions about gout in the latest video released today on MerckManuals.com. Below are the highlights:

What is it?

Gout is a common and painful disorder that results from deposits of uric acid crystals accumulating in the joints because of high levels of uric acid in the blood. When the crystals accumulate, painful "attacks" of inflammation result in the joints.

"It's as if you were making yourself an iced tea," says Dr. Mandell in the video. "Say you poured sugar into that iced tea and you stirred it up and it goes in perfectly fine, but you add some more in and you stir it up and it settles out in the bottom of that glass. That's what happens with uric acid when it's too high in our blood, it settles out in and around joints."

What are the symptoms?

Symptoms of gout include acute sudden onset of severe pain in one or more of the joints. Any joint in the body can be affected by gout, and attacks often occur at night. The joint will become inflamed, red and extremely painful to the touch. One of the most common features of gout is podagra, a sudden pain with redness and swelling in the big toe.

Who is affected?

It is estimated that 6 million adults age 20 and older have experienced gout at some point. It's a genetic disorder that's more common among men, and it usually develops during middle age in men and after menopause in women. Gout is rare in younger people but is often more severe in those who develop the disorder before the age of 30.

Other risk factors include obesity, high intake of beer and liquor, high intake of foods and drinks containing high fructose corn syrup, low intake of dairy, chronic kidney disease and certain medications that could raise the levels of uric acid in the blood.

How is it treated?

The symptoms of gout can be easily treated with nonsteroidal anti-inflammatory drugs (NSAIDS) or corticosteroids to reduce pain and inflammation. Those experiencing an attack should also rest, ice and immobilize the inflamed area if necessary to rid themselves of the painful symptoms. However, to get to the root of the gout disease and prevent flare ups in the future, patients must take several medications to get rid of the deposits of uric acid crystals. This treatment could take years to fully dissolve the deposits.

Can lifestyle changes reduce the risk?

Yes, making dietary changes can lower the risk of getting gout. Avoid eating too much of any food that is rich in purine (bacon, lamb, scallops, anchovies, etc.), anything containing high levels of high-fructose corn syrup, and drinking liquor and beer, including nonalcoholic beer. As weight gain is considered a risk factor for gout, maintaining a healthy exercise routine is also recommended.

"As far as dietary changes, we generally recommend a healthy, "common sense" diet avoiding excess, and my own advice to people in general is you should avoid drinking cheap wine," said Mandell.

About The Merck Manuals

First published in 1899 as a small reference book for physicians and pharmacists, The Merck Manual grew in size and scope to become one of the world's most widely used comprehensive medical resources for professionals and consumers. As The Manual evolved, it continually expanded the reach and depth of its offerings to reflect the mission of providing the best medical information to a wide cross-section of users, including medical professionals and students, veterinarians and veterinary students, and consumers. In 2015, The Merck Manual kicked off Global Medical Knowledge 2020, a program to make the best current medical information accessible by up to three billion professionals and patients around the world by 2020. For access to thousands of medical topics with images, videos and a constantly expanding set of resources, visit MerckManuals.com and connect with us on social media:

For Consumers in the U.S. and its territories: Twitter and Facebook

For Professionals in the U.S. and its territories: Twitter and Facebook

About Merck

For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on TwitterFacebookInstagram, YouTube and LinkedIn.

SOURCE MerckManuals.com


These press releases may also interest you

8 déc 2017
Her Excellency the Right Honourable Julie Payette, Governor General of Canada, will present the Meritorious Service Decorations (Civil Division) to 42 recipients from various sectors across the country on Tuesday, December 12, 2017, at 10:30 a.m.,...

8 déc 2017
Restated segment financials As announced in April 2017, Ericsson will start to report financials according to its new segments as of the fourth quarter 2017. To facilitate year-on-year comparisons, Ericsson today discloses the restated financials...

7 déc 2017
In the search for drugs that are effective against Ebola virus, scientists from SRI International and Collaborations Pharmaceuticals, Inc., led a study that used machine learning methods to identify tilorone dihydrochloride as a potential new...

7 déc 2017
Replikins Ltd. this week reported to the Healthcare Emergency Management Program of Boston University School of Medicine a four-fold increase in gene Replikin Counts in Global MERS-CoV from 2008 to 2017 (p<0.001) ? the highest ever recorded on...

6 déc 2017
Meda Aktiebolag has successfully amended the terms and conditions of two series of notes issued pursuant to its SEK 7,000,000,000 medium term notes programme and inserted an early redemption call option which it will exercise with immediate effect...

6 déc 2017
NanoViricides, Inc. (the "Company") reports that it has begun initial safety and toxicology evaluation of its optimized nanoviricides® drug candidates developed against varicella-zoster virus (VZV), the shingles virus.  This study is an important...




News published on 27 september 2017 at 14:16 and distributed by: